Literature DB >> 18161925

Choice of laxatives and colonoscopic preparation in pregnant patients from the viewpoint of obstetricians and gastroenterologists.

Jeevan Vinod1, Jennifer Bonheur, Burton I Korelitz, Georgia Panagopoulos.   

Abstract

AIM: To elucidate the preferences of gastroenterologists at our institution and compare them to those of obstetricians when making decisions in the pregnant patient, including which type of bowel preparations to use for flexible sigmoidoscopy or colonoscopy, as well as which laxatives can be used safely.
METHODS: Surveys were mailed to all attending gastroenterologists (n = 53) and obstetricians (n = 99) at our institution. Each survey consisted of the 14 most common laxative or motility agents used in pregnancy and inquired about the physician's prescribing habits in the past as well as their willingness to prescribe each medication in the future. The survey also listed four common bowel preparations used prior to colonoscopy and sigmoidoscopy and asked the physician to rank the order of the preferred agent in each case.
RESULTS: With regard to common laxatives, both gastroenterologists and obstetricians favor the use of Metamucil, Colace, and Citrucel. Both groups appear to refrain from using Fleets Phosphosoda and Castor oil. Of note, obstetricians are less inclined to use PEG solution and Miralax, which is not the case with gastroenterologists. In terms of comparing bowel preparations for colonoscopy, 50% of gastroenterologists prefer to use PEG solution and 50% avoid the use of Fleets Phosphosoda. Obstetricians seem to prefer Fleets Phosphosoda (20%) and tend to avoid the use of PEG solution (26%). With regard to bowel preparation for sigmoidoscopy, both groups prefer Fleets enema the most (51%), while magnesium citrate is used least often (38%).
CONCLUSION: It is clear that preferences in the use of bowel cleansing preparations between the two groups exist, but there have not been many case controlled human studies in the pregnant patient that give clear cut indications for using one versus another drug. In light of the challenge of performing controlled trials in pregnant women, more extensive surveys should be undertaken to gather a larger amount of data on physician's experiences and individual preferences.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18161925      PMCID: PMC4611294          DOI: 10.3748/wjg.v13.i48.6549

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  12 in total

1.  Uterine rupture associated with castor oil ingestion.

Authors:  G B Sicuranza; R Figueroa
Journal:  J Matern Fetal Neonatal Med       Date:  2003-02

Review 2.  The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy.

Authors:  Mitchell S Cappell
Journal:  Gastroenterol Clin North Am       Date:  2003-03       Impact factor: 3.806

3.  Acute phosphate nephropathy and renal failure.

Authors:  Simon Desmeules; Marc J Bergeron; Paul Isenring
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

Review 4.  American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy.

Authors:  Uma Mahadevan; Sunanda Kane
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

5.  Connatal rickets following repeated administration of phosphate enemas in pregnancy: a case report.

Authors:  P Rimensberger; G Schubiger; U Willi
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

Review 6.  Endoscopy in the pregnant patient with inflammatory bowel disease.

Authors:  Jeffry A Katz
Journal:  Gastrointest Endosc Clin N Am       Date:  2002-07

7.  Multicenter, multiyear study of safety and efficacy of flexible sigmoidoscopy during pregnancy in 24 females with follow-up of fetal outcome.

Authors:  M S Cappell; O Sidhom
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 8.  Constipation and diarrhea in pregnancy.

Authors:  E S Bonapace; R S Fisher
Journal:  Gastroenterol Clin North Am       Date:  1998-03       Impact factor: 3.806

9.  The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome.

Authors:  P J Baiocco; B I Korelitz
Journal:  J Clin Gastroenterol       Date:  1984-06       Impact factor: 3.062

Review 10.  The irritable bowel syndrome during pregnancy.

Authors:  William L Hasler
Journal:  Gastroenterol Clin North Am       Date:  2003-03       Impact factor: 3.806

View more
  1 in total

Review 1.  Risks versus benefits of gastrointestinal endoscopy during pregnancy.

Authors:  Mitchell S Cappell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.